Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

739
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
739

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoma or sarcoma.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2025
Same author

Chest drainage - indications, technique, and management of complications.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2025
Same author

From ice to refrigerator - innovations in static donor lung preservation.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2025
Same author

Treatment Responses in Histologic Versus Molecular Diagnoses of Lung Rejection.

Transplant international : official journal of the European Society for Organ Transplantation·2024
Same author

Surgical therapy of chronic lung allograft dysfunction.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2024
Same author

Robotic pulmonary segmentectomy, initial experience in the Czech Republic.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2023
Same journal

Rare causes of pneumoperitoneum.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2026
Same journal

Imaging of pneumoperitoneum.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2026
Same journal

Postoperative pneumoperitoneum.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2026
Same journal

Pneumoperitoneum of the lower gastrointestinal tract.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2026
Same journal

Pneumoperitoneum in dis-eases and traumas of the upper part of the digestive tract -  an overview of current knowledge and clinical context.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2026
Same journal

Pseudoaneurysm arteria carotis.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2026
See all related articles

Related Experiment Video

Updated: Nov 28, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.2K

Malignancy after lung transplantation.

M Švorcová, J Havlín, J Vachtenheim

    Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti
    |November 27, 2020
    PubMed
    Summary
    This summary is machine-generated.

    Malignancies are a significant cause of death after lung transplantation, with lung cancer being the most common. Regular cancer screening is crucial for early detection and improved outcomes in transplant recipients.

    Keywords:
    Lung transplantation

    More Related Videos

    Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
    06:03

    Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

    Published on: January 19, 2019

    17.7K
    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
    04:04

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

    Published on: February 12, 2017

    10.7K

    Related Experiment Videos

    Last Updated: Nov 28, 2025

    Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
    06:15

    Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

    Published on: November 10, 2023

    1.2K
    Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
    06:03

    Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

    Published on: January 19, 2019

    17.7K
    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
    04:04

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

    Published on: February 12, 2017

    10.7K

    Area of Science:

    • Cardiology
    • Oncology
    • Transplantation Medicine

    Background:

    • Lung transplantation is a life-saving procedure for end-stage pulmonary disease.
    • Malignancies are the third leading cause of death post-lung transplant, particularly 5-10 years after the procedure.
    • Risk factors for post-transplant malignancy include immunosuppressive therapy, older age, oncogenic virus infections, and smoking history.

    Purpose of the Study:

    • To analyze the incidence, types, and locations of tumors in lung transplant recipients.
    • To determine the time to tumor detection, survival rates, and causes of death in these patients.

    Main Methods:

    • Retrospective evaluation of lung transplant patients between 2010 and 2019.
    • Analysis of tumor characteristics, including type, location, and time of detection.
    • Assessment of survival time and causes of death.

    Main Results:

    • Lung cancer was the most frequent malignancy (37%), followed by non-melanoma skin cancer (17%) and post-transplant lymphoproliferative disease (12.5%).
    • Out of 308 lung transplantations, 32 patients were diagnosed with post-transplant malignancy.
    • The mean survival time after malignancy diagnosis was 152 days.

    Conclusions:

    • Long-term immunosuppressive therapy, while vital for preventing rejection, increases cancer risk in lung transplant recipients.
    • Oncological management involves reducing immunosuppression, surgical resection, and other cancer therapies.
    • Regular oncology screening is recommended for early tumor detection and prevention in lung transplant patients.